Catalyst Wire Dossier Catalyst Wire Dossier

Lentiviral gene therapy for X-ALD (intrathecal and intravenous delivery)

· Shenzhen Geno-Immune Medical Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lentiviral gene therapy for X-ALD (intrathecal and intravenous delivery), covering 2025-09-09 to 2025-09-09. Get the full timeline:

Most recent: Clinical Trial Update: IT and IV Lentiviral Gene Therapy for X-ALD [NA]

See pricing